Physicochemical Properties
| Molecular Formula | C19H13CLF6N4O2 |
| Molecular Weight | 478.7755 |
| Exact Mass | 478.063 |
| CAS # | 952510-14-4 |
| Related CAS # | 952565-91-2; |
| PubChem CID | 16755142 |
| Appearance | Off-white to light yellow solid powder |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 32 |
| Complexity | 621 |
| Defined Atom Stereocenter Count | 1 |
| SMILES | C[C@@H](C(F)(F)F)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=CC4=C(C=C3)N=CN4)C(F)(F)F.Cl |
| InChi Key | KRUYZACYZSOZCV-FVGYRXGTSA-N |
| InChi Code | InChI=1S/C19H12F6N4O2.ClH/c1-9(18(20,21)22)30-15-5-3-11(6-12(15)19(23,24)25)17-28-16(29-31-17)10-2-4-13-14(7-10)27-8-26-13;/h2-9H,1H3,(H,26,27);1H/t9-;/m0./s1 |
| Chemical Name | 3-(3H-benzimidazol-5-yl)-5-[3-(trifluoromethyl)-4-[(2S)-1,1,1-trifluoropropan-2-yl]oxyphenyl]-1,2,4-oxadiazole;hydrochloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vivo | ASP4058 (oral, once daily for 21 days) hydrochloride lowered clinical scores in a dose-dependent manner, with cumulative clinical scores of 15.5±1.48 and 9.50 from day 0 to 21 dpi at 0.03, 0.1 and 0.3 mg/kg, respectively. ±2.17 and ±1.17 in rats respectively, while it was 15.5±0.619 in the vehicle-treated group. ASP4058 reduces weight loss in EAE rats [1]. ASP4058 hydrochloride (oral, daily for 12 to 45 days) maintained clinical scores at reasonably low levels, with a cumulative clinical score (18-45 dpi) of 6.90 ± 2.85 in mice given with doses of 0.1 and 0.3 mg/kg. are 5.60±2.21 correspondingly. The ED50 value of ASP4058 is 0.063 mg/kg[1]. |
| References |
[1]. ASP4058, a Novel Agonist for Sphingosine 1-Phosphate Receptors 1 and 5, Ameliorates Rodent Experimental Autoimmune Encephalomyelitis with a Favorable Safety Profile. PLoS One. 2014 Oct 27;9(10):e110819. |
Solubility Data
| Solubility (In Vitro) |
DMSO : ~200 mg/mL (~417.73 mM) H2O : < 0.1 mg/mL |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 5 mg/mL (10.44 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.0886 mL | 10.4432 mL | 20.8864 mL | |
| 5 mM | 0.4177 mL | 2.0886 mL | 4.1773 mL | |
| 10 mM | 0.2089 mL | 1.0443 mL | 2.0886 mL |